IMPACT trial: Roche’s CINtec PLUS Cytology shows higher sensitivity in detecting cervical pre-cancers in HPV-positive women compared to Pap cytology

Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in the International Journal of Cancer, the IMPACT (IMproving Primary screening And Colposcopy … Read the full press release →